The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Open accessAbstract
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) substantially challenges TB control, especially in the European Region of the World Health Organization, where the highest prevalence of MDR/XDR cases is reported. The current management of patients with MDR/XDR-TB is extremely complex for medical, social and public health systems. The treatment with currently available anti-TB therapies to achieve relapse-free cure is long and undermined by a high frequency of adverse drug events, suboptimal treatment adherence, high costs and low treatment success rates. Availability of optimal management for patients with MDR/XDR-TB is limited even in the European Region. In the absence of a preventive vaccine, more effective diagnostic tools and novel therapeutic interventions the control of MDR/XDR-TB will be extremely difficult. Despite recent scientific advances in MDR/XDR-TB care, decisions for the management of patients with MDR/XDR-TB and their contacts often rely on expert opinions, rather than on clinical evidence. This document summarises the current knowledge on the prevention, diagnosis and treatment of adults and children with MDR/XDR-TB and their contacts, and provides expert consensus recommendations on questions where scientific evidence is still lacking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Unicef, U. (2011) · Cited by 1,292
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Global tuberculosis control 2010
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,262
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_3.ats600 · Cited by 1,241
Hospital Epidemiology and Infection Control
Mayhall, C. G. (2011) · Cited by 1,179
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Self-citationMolecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., van Soolingen, D., Jensen, P., & Bayona, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60410-2 · Cited by 1,018
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
(2016) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610020190-part06-targeted · Cited by 920
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017863 · Cited by 805
Fox, W., Ellard, G. A., & Mitchison, D. A. (1999) · PubMed · Cited by 797
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli
Behr, M., Warren, S., Salamon, H., Hopewell, P., de Leon, A. P., Daley, C., & Small, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03406-0 · Cited by 754
The changing model of palliative care
Graham, F., & Clark, D. (2008) · Medicine · doi:10.1016/j.mpmed.2007.11.009 · Cited by 743
Systematic review and meta-analysis of psychological therapies for children with chronic pain
Fisher, E., Heathcote, L., Palermo, T. M., de C Williams, A. C., Lau, J., & Eccleston, C. (2014) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsu008 · Cited by 710
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Van Deun, A., Maug, A. K. J., Salim, M. A. H., Das, P. K., Sarker, M. R., Daru, P., & Rieder, H. L. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0077oc · Cited by 647
National Survey of Drug-Resistant Tuberculosis in China
Zhao, Y., Xu, S., Wang, L., Chin, D. P., Wang, S., Jiang, G., Xia, H., Zhou, Y., Li, Q., Ou, X., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108789 · Cited by 631
Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
Velayati, A. A., Masjedi, M. R., Farnia, P., Tabarsi, P., Ghanavi, J., ZiaZarifi, A. H., & Hoffner, S. E. (2009) · Chest · doi:10.1378/chest.08-2427 · Cited by 607
Martineau, A. R., Timms, P. M., Bothamley, G. H., Hanifa, Y., Islam, K., Claxton, A. P., Packe, G. E., Moore-Gillon, J. C., Darmalingam, M., Davidson, R. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61889-2 · Cited by 580
Self-citationBest drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Caminero, J. A., Sotgiu, G., Zumla, A., & Migliori, G. B. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70139-0 · Cited by 574
Self-citationOrenstein, E. W., Basu, S., Shah, N. S., Andrews, J. R., Friedland, G. H., Moll, A. P., Gandhi, N. R., & Galvani, A. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70041-6 · Cited by 540
Tuberculosis surveillance and monitoring in Europe 2012.
Dara, M., Kremer, K., Huitric, E., Ködmön, C., & Zucs, P. (2012) · Cited by 537
Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M., Centis, R., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001300 · Cited by 535
Self-citationTiming of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Havlir, D. V., Kendall, M. A., Ive, P., Kumwenda, J., Swindells, S., Qasba, S. S., Luetkemeyer, A. F., Hogg, E., Rooney, J. F., Wu, X., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013607 · Cited by 532
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Totally Drug-Resistant Tuberculosis in India
Udwadia, Z. F., Amale, R. A., Ajbani, K. K., & Rodrigues, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir889 · Cited by 527
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Integration of Antiretroviral Therapy with Tuberculosis Treatment
Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayatchi, N., Baxter, C., Gray, A. L., Gengiah, T., Gengiah, S., Naidoo, A., Jithoo, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014181 · Cited by 487
HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
Wells, C. D., Cegielski, J. P., Nelson, L. J., Laserson, K. F., Holtz, T. H., Finlay, A., Castro, K. G., & Weyer, K. (2007) · The Journal of Infectious Diseases · doi:10.1086/518665 · Cited by 483
Risk factors for multidrug resistant tuberculosis in Europe: a systematic review
Faustini, A. (2006) · Thorax · doi:10.1136/thx.2005.045963 · Cited by 455
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
Pasipanodya, J. G., McIlleron, H., Burger, A., Wash, P. A., Smith, P., & Gumbo, T. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit352 · Cited by 444
Diacon, A. H., Dawson, R., von Groote-Bidlingmaier, F., Symons, G., Venter, A., Donald, P. R., van Niekerk, C., Everitt, D., Winter, H., Becker, P., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61080-0 · Cited by 435
International standards of tuberculosis care.
Mohan, A. (2006) · PubMed · Cited by 432
Sotgiu, G., Centis, R., D'Ambrosio, L., Alffenaar, J.-W. C., Anger, H. A., Caminero, J. A., Castiglia, P., De Lorenzo, S., Ferrara, G., Koh, W.-J., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00022912 · Cited by 416
Self-citationFalzon, D., Gandhi, N., Migliori, G. B., Sotgiu, G., Cox, H. S., Holtz, T. H., Hollm-Delgado, M.-G., Keshavjee, S., DeRiemer, K., Centis, R., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00134712 · Cited by 388
Self-citationMechanisms of Drug Resistance in Mycobacterium tuberculosis
Heym, B., Philipp, W., & Cole, S. T. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80166-2_3 · Cited by 379
Global tuberculosis drug development pipeline: the need and the reality
Ma, Z., Lienhardt, C., McIlleron, H., Nunn, A. J., & Wang, X. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60359-9 · Cited by 374
Clofazimine: current status and future prospects
Cholo, M. C., Steel, H. C., Fourie, P. B., Germishuizen, W. A., & Anderson, R. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr444 · Cited by 351
Natural Ventilation for Infection Control in Health-care Settings
Atkinson, J., Chartier, Y., Pessoa-Silva, C. L., Jensen, P. A., Li, Y., & Seto, W. (2010) · Virtual Defense Library (Ministerio de Defensa) · Cited by 345
Rustomjee, R., Lienhardt, C., Kanyok, T. P., Davies, G., Levin, J., Mthiyane, T., Reddy, C., Sturm, A. W., Sirgel, F. A., Allen, J., et al. (2008) · PubMed · Cited by 326
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
Self-citationLifetime Risks, Incubation Period, and Serial Interval of Tuberculosis
Vynnycky, E. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.3.247 · Cited by 322
Gumbo, T., Louie, A., Deziel, M. R., Parsons, L. M., Salfinger, M., & Drusano, G. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/424849 · Cited by 315
Gandhi, N. R., Shah, N. S., Andrews, J. R., Vella, V., Moll, A. P., Scott, M., Weissman, D., Marra, C., Lalloo, U. G., & Friedland, G. H. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-0989oc · Cited by 313
Riley, R. L., MILLS, C. C., O'Grady, F., SULTAN, L. U., Wittstadt, F. B., & Shivpuri, D. (1962) · PubMed · doi:10.1164/arrd.1962.85.4.511 · Cited by 313
Transmission of tubercle bacilli: The effects of chemotherapy
Rouillon, A., Perdrizet, S., & Parrot, R. (1976) · Tubercle · doi:10.1016/s0041-3879(76)80006-2 · Cited by 310
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010
Zignol, M., van Gemert, W., Falzon, D., Sismanidis, C., Glaziou, P., Floyd, K., & Raviglione, M. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.092585 · Cited by 295
Drug-susceptibility testing in tuberculosis: methods and reliability of results
Kim, S. J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00111304 · Cited by 285
京都大学グローバルCOEプログラムアジア・メガシティの人間安全保障工学拠点 (2010) · Medical Entomology and Zoology · Cited by 282
Tuberculosis contact investigation in low prevalence countries: a European consensus
Erkens, C. G. M., Kamphorst, M., Abubakar, I., Bothamley, G. H., Chemtob, D., Haas, W., Migliori, G. B., Rieder, H. L., Zellweger, J.-P., & Lange, C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00201609 · Cited by 272
Self-citationInfectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis.
Borrell, S., & Gagneux, S. (2009) · PubMed · Cited by 270
Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial Diseases
Peloquin, C. A., Berning, S. E., Nitta, A. T., Simone, P. M., Goble, M., Huitt, G. A., Iseman, M. D., Cook, J. L., & Curran-Everett, D. (2004) · Clinical Infectious Diseases · doi:10.1086/420742 · Cited by 270
RILEY, R. L., MILLS, C. C., NYKA, W., WEINSTOCK, N., STOREY, P. B., SULTAN, L. U., RILEY, M. C., & WELLS, W. F. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117542 · Cited by 269
Drug-resistant tuberculosis: time for visionary political leadership
Abubakar, I., Zignol, M., Falzon, D., Raviglione, M., Ditiu, L., Masham, S., Adetifa, I., Ford, N., Cox, H., Lawn, S. D., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70030-6 · Cited by 269
Self-citationDorman, S. E., Johnson, J. L., Goldberg, S., Muzanye, G., Padayatchi, N., Bozeman, L., Heilig, C. M., Bernardo, J., Choudhri, S., Grosset, J. H., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0078oc · Cited by 264
Self-citationMechanisms of Drug Resistance in Mycobacterium tuberculosis
Zhang, Y., Vilchèze, C., & Jacobs, W. R. (2004) · Tuberculosis and the Tubercle Bacillus · doi:10.1128/9781555817657.ch8 · Cited by 261
Antituberculosis drugs and hepatotoxicity
YEW, W. W., & LEUNG, C. C. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00941.x · Cited by 256
Self-citationXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253
Georghiou, S. B., Magana, M., Garfein, R. S., Catanzaro, D. G., Catanzaro, A., & Rodwell, T. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033275 · Cited by 249
Dheda, K., Shean, K., Zumla, A., Badri, M., Streicher, E. M., Page-Shipp, L., Willcox, P., John, M.-A., Reubenson, G., Govindasamy, D., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60492-8 · Cited by 246
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard
Van Deun, A., Aung, K. J. M., Bola, V., Lebeke, R., Hossain, M. A., de Rijk, W. B., Rigouts, L., Gumusboga, A., Torrea, G., & de Jong, B. C. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00553-13 · Cited by 241
Aubry, A., Pan, X.-S., Fisher, L. M., Jarlier, V., & Cambau, E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1281-1288.2004 · Cited by 240
Drobniewski, F. (2005) · JAMA · doi:10.1001/jama.293.22.2726 · Cited by 235
Self-citationLoebstein, R., Addis, A., Ho, E., Andreou, R., Sage, S., Donnenfeld, A. E., Schick, B., Bonati, M., Moretti, M., Lalkin, A., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1336 · Cited by 229
European Union Standards for Tuberculosis Care
Migliori, G. B., Zellweger, J. P., Abubakar, I., Ibraim, E., Caminero, J. A., De Vries, G., D'Ambrosio, L., Centis, R., Sotgiu, G., Menegale, O., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00203811 · Cited by 213
Self-citationSuárez, P. G., Floyd, K., Portocarrero, J., Alarcón, E., Rapiti, E., Ramos, G., Bonilla, C., Sabogal, I., Aranda, I., Dye, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08830-x · Cited by 211
Shandil, R. K., Jayaram, R., Kaur, P., Gaonkar, S., Suresh, B. L., Mahesh, B. N., Jayashree, R., Nandi, V., Bharath, S., & Balasubramanian, V. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00414-06 · Cited by 203
Larsen, M. H., Vilchèze, C., Kremer, L., Besra, G. S., Parsons, L., Salfinger, M., Heifets, L., Hazbon, M. H., Alland, D., Sacchettini, J. C., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03162.x · Cited by 202
Johnson, J. L., Hadad, D. J., Boom, W. H., Daley, C. L., Peloquin, C. A., Eisenach, K. D., Jankus, D. D., Debanne, S. M., Charlebois, E. D., Maciel, E. L. N., et al. (2006) · PubMed · Cited by 200
Fitzpatrick, C., & Floyd, K. (2012) · PharmacoEconomics · doi:10.2165/11595340-000000000-00000 · Cited by 186
Peloquin, C. A., Hadad, D. J., Molino, L. P. D., Palaci, M., Boom, W. H., Dietze, R., & Johnson, J. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01036-07 · Cited by 185
The Infectiousness of Tuberculosis Patients Coinfected with HIV
Escombe, A. R., Moore, D. A. J., Gilman, R. H., Pan, W., Navincopa, M., Ticona, E., Martínez, C., Caviedes, L., Sheen, P., Gonzalez, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050188 · Cited by 182
Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB
Von Groll, A., Martin, A., Jureen, P., Hoffner, S., Vandamme, P., Portaels, F., Palomino, J. C., & da Silva, P. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00287-09 · Cited by 181
Variability of Infectious Aerosols Produced during Coughing by Patients with Pulmonary Tuberculosis
Fennelly, K. P., Jones-López, E. C., Ayakaka, I., Kim, S., Menyha, H., Kirenga, B., Muchwa, C., Joloba, M., Dryden-Peterson, S., Reilly, N., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0444oc · Cited by 172
Stuckler, D., Basu, S., McKee, M., & King, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801200105 · Cited by 172
Dharmadhikari, A. S., Mphahlele, M., Stoltz, A., Venter, K., Mathebula, R., Masotla, T., Lubbe, W., Pagano, M., First, M., Jensen, P. A., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201107-1190oc · Cited by 170
Gelmanova, I. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.038331 · Cited by 170
Wejse, C., Gustafson, P., Nielsen, J., Gomes, V. F., Aaby, P., Andersen, P. L., & Sodemann, M. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701558698 · Cited by 170
Ettehad, D., Schaaf, H. S., Seddon, J. A., Cooke, G. S., & Ford, N. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70033-6 · Cited by 168
Lienhardt, C., Raviglione, M., Spigelman, M., Hafner, R., Jaramillo, E., Hoelscher, M., Zumla, A., & Gheuens, J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis034 · Cited by 167
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors
Skrahina, A., Hurevich, H., Zalutskaya, A., Sahalchyk, E., Astrauko, A., Hoffner, S., Rusovich, V., Dadu, A., de Colombani, P., Dara, M., et al. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.104588 · Cited by 166
Self-citationAerial dissemination of pulmonary tuberculosis.
Riley, R. L. (1957) · PubMed · doi:10.1164/artpd.1957.76.6.931 · Cited by 166
Suárez, Floyd, Portocarrero, & Alarcon (2002) · The Lancet · Cited by 166
Interventions for tuberculosis control and elimination.
Rieder, H. L., & Disease, L. (2002) · Cited by 162
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Skrahina, A., Hurevich, H., Zalutskaya, A., Sahalchyk, E., Astrauko, A., van Gemert, W., Hoffner, S., Rusovich, V., & Zignol, M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00145411 · Cited by 162
Self-citationGreco, S., Girardi, E., Navarra, A., & Saltini, C. (2006) · Thorax · doi:10.1136/thx.2005.054908 · Cited by 162
Iseman, M. D., Madsen, L., Goble, M., & Pomerantz, M. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.3.623 · Cited by 162
How Contagious Is Tuberculosis?
Sepkowitz, K. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.954 · Cited by 160
Rachow, A., Zumla, A., Heinrich, N., Rojas-Ponce, G., Mtafya, B., Reither, K., Ntinginya, E. N., O'Grady, J., Huggett, J., Dheda, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020458 · Cited by 160
De Lorenzo, S., Alffenaar, J. W., Sotgiu, G., Centis, R., D'Ambrosio, L., Tiberi, S., Bolhuis, M. S., van Altena, R., Viggiani, P., Piana, A., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00124312 · Cited by 160
Self-citationMicroepidemics of tuberculosis: the stone-in-the-pond principle
Veen, J. (1992) · Tubercle and Lung Disease · doi:10.1016/0962-8479(92)90058-r · Cited by 159
Pediatric tuberculosis: time for a new approach
Starke, J. R. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00088-4 · Cited by 153
Traore, H., Fissette, K., Bastian, I., Devleeschouwer, M. J., & Portaels, F. (2000) · PubMed · Cited by 152
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
Eker, B., Ortmann, J., Migliori, G. B., Sotgiu, G., Mütterlein, R., Centis, R., Hoffmann, H., Kirsten, D. K., Schaberg, T., Ruesch-Gerdes, S., et al. (2008) · Emerging infectious diseases · doi:10.3201/eid1411.080729 · Cited by 151
Self-citationKurbatova, E. V., Taylor, A. B., Gammino, V. M., Bayona, J. N., Becerra, M. C., Danilovitz, M., Falzon, D., Gelmanova, I. Y., Keshavjee, S. A., Leimane, V., et al. (2012) · Tuberculosis · doi:10.1016/j.tube.2012.06.003 · Cited by 145
Transmission of Tuberculosis to Close Contacts of Patients With Multidrug-Resistant Tuberculosis
Kritski, A. L., Marques, M. J., Rabahi, M. F., Vieira, M. A. M. S., Werneck-Barroso, E., Carvalho, C. E., Andrade, G. D. N., Bravo-de-Souza, R., Andrade, L. M., Gontijo, P. P., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.1.8542139 · Cited by 144
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Cole, S. T. (1994) · Immunobiology · doi:10.1016/s0171-2985(11)80466-3 · Cited by 140
Becerra, M. C., Appleton, S. C., Franke, M. F., Chalco, K., Arteaga, F., Bayona, J. N., Murray, M. B., Atwood, S. S., & Mitnick, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61972-1 · Cited by 138
Tuberculosis case-finding and chemotherapy: Questions and answers
Toman, K. (1979) · Cited by 138
Getahun, H., Sculier, D., Sismanidis, C., Grzemska, M., & Raviglione, M. C. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis009 · Cited by 135
Treatment of non-specific vaginitis with metronidazole.
Jerve, F., Qvigstad, E., & Eng, J. (1983) · PubMed · Cited by 134
Toczek, A., Cox, H. S., du Cros, P., Cooke, G., & Ford, N. P. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0537 · Cited by 133
Pfyffer, G. E., Bonato, D. A., Ebrahimzadeh, A., Gross, W. M., Hotaling, J. E., Kornblum, J. S., Laszlo, A., Roberts, G. D., Salfinger, M., Wittwer, F., et al. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.10.3179-3186.1999 · Cited by 133
Krüüner, A., Yates, M. D., & Drobniewski, F. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.811-818.2006 · Cited by 126
Self-citationMycobacterium tuberculosisBeijing Genotype and Risk for Treatment Failure and Relapse, Vietnam
Lan, N. T. N., Lien, H. T. K., Tung, L. B., Borgdorff, M. W., Kremer, K., & van Soolingen, D. (2003) · Emerging infectious diseases · doi:10.3201/eid0912.030169 · Cited by 125
Tupasi, T. E., Gupta, R., Quelapio, M. I. D., Orillaza-Chi, R., Mira, N. R. C., Mangubat, N. V., Belen, V., Arnisto, N., Macalintal, L., Arabit, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030352 · Cited by 123
Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis
van der Werf, M. J., Langendam, M. W., Huitric, E., & Manissero, D. (2011) · European Respiratory Journal · doi:10.1183/09031936.00125711 · Cited by 122
Fitting Characteristics of Eighteen N95 Filtering-Facepiece Respirators
Coffey, C. C., Lawrence, R. B., Campbell, D. L., Zhuang, Z., Calvert, C. A., & Jensen, P. A. (2004) · Journal of Occupational and Environmental Hygiene · doi:10.1080/15459620490433799 · Cited by 119
Pasipanodya, J. G., & Gumbo, T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00749-10 · Cited by 118
A Cholesterol-Rich Diet Accelerates Bacteriologic Sterilization in Pulmonary Tuberculosis
Pérez-Guzmán, C., Vargas, M. H., Quiñonez, F., Bazavilvazo, N., & Aguilar, A. (2005) · CHEST Journal · doi:10.1378/chest.127.2.643 · Cited by 116
Behr, M. A., Hopewell, P. C., PAZ, E. A., Kawamura, L. M., Schecter, G. F., & Small, P. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.2.9801062 · Cited by 113
Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection
O’Donnell, M. R., Padayatchi, N., Kvasnovsky, C., Werner, L., Master, I., & Horsburgh, C. R. (2013) · Emerging infectious diseases · doi:10.3201/eid1903.120998 · Cited by 111
Brust, J. C. M., Shah, N. S., Scott, M., Chaiyachati, K. H., Lygizos, M. I., van der Merwe, T. L., Bamber, S., Radebe, Z., Loveday, M., Moll, A. P., et al. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0713 · Cited by 110
Diagnosis of pulmonary tuberculosis in children: new advances
Zar, H. J., Connell, T. G., & Nicol, M. P. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.9 · Cited by 110
Nervous System Effects of Antituberculosis Therapy
Kass, J. S., & Shandera, W. X. (2010) · CNS Drugs · doi:10.2165/11534340-000000000-00000 · Cited by 109
The ins and outs of Mycobacterium tuberculosis drug susceptibility testing
Böttger, E. C. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03551.x · Cited by 108
Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004.
Bloss, E., Kukša, L., Holtz, T. H., et al. (2010) · PubMed · Cited by 107
Treatment of tuberculosis: update 2010
Yew, W. W., Lange, C. G., & Leung, C. C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00033010 · Cited by 104
Self-citationXu, P., Kujundzic, E., Peccia, J., Schafer, M. P., Moss, G., Hernandez, M., & Miller, S. L. (2005) · Environmental Science & Technology · doi:10.1021/es0504892 · Cited by 102
Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection.
Deun, A. V., Martin, A., & Palomino, J. C. (2010) · PubMed · Cited by 94
Crudu, V., Stratan, E., Romancenco, E., Allerheiligen, V., Hillemann, A., & Moraru, N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05903-11 · Cited by 92
Self-citationSubstandard and falsified anti-tuberculosis drugs: a preliminary field analysis
Bate, R., Jensen, P. A., Hess, K., Mooney, L., & Milligan, J. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0355 · Cited by 91
Community-Based Therapy for Children With Multidrug-Resistant Tuberculosis
Drobac, P. C., Mukherjee, J. S., Joseph, J. K., Mitnick, C. D., Furin, J. J., Castillo, H. D., Shin, S. S., & Becerra, M. C. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2235 · Cited by 89
Laurenzo, D., & Mousa, S. A. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2011.04.008 · Cited by 88
Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future
Lehloenya, R. J., & Dheda, K. U. J. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.13 · Cited by 88
Treatment of Multidrug‐Resistant Tuberculosis during Pregnancy: A Report of 7 Cases
Shin, S. S., Guerra, D., Rich, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374225 · Cited by 86
Chang, K. C., Yew, W.-W., Tam, C. M., & Leung, C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00120-13 · Cited by 86
Self-citationNew Diagnostics for Latent and Active Tuberculosis: State of the Art and Future Prospects
Pai, M., & O'Brien, R. (2008) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0028-1085707 · Cited by 85
Via, L. E., Cho, S.-N., Hwang, S., Bang, H., Park, S. K., Kang, H. S., Jeon, D., Min, S., Oh, T., Kim, Y., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01476-09 · Cited by 83
Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians
Schaaf, H. S., & Marais, B. J. (2010) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2010.09.010 · Cited by 81
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience
Pranger, A. D., van Altena, R., Aarnoutse, R. E., van Soolingen, D., Uges, D. R. A., Kosterink, J. G. W., van der Werf, T. S., & Alffenaar, J. C. (2011) · European Respiratory Journal · doi:10.1183/09031936.00176610 · Cited by 81
Self-citationRodríguez, J. C., Cebrián, L., López, M., Ruiz, M., Jiménez, I., & Royo, G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh119 · Cited by 80
Drug‐Resistant Tuberculosis and Pregnancy: Treatment Outcomes of 38 Cases in Lima, Peru
Palacios, E., Dallman, R., Muñoz, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598191 · Cited by 80
Isaakidis, P., Cox, H. S., Varghese, B., Montaldo, C., Silva, E. D., Mansoor, H., Ladomirska, J., Sotgiu, G., Migliori, G. B., Pontali, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028066 · Cited by 79
Lee, K., Slavcev, A., & Nicas, M. (2004) · Journal of Occupational and Environmental Hygiene · doi:10.1080/15459620490250026 · Cited by 77
Multidrug Resistance Among Persons With Tuberculosis in California, 1994-2003
Granich, R. (2005) · JAMA · doi:10.1001/jama.293.22.2732 · Cited by 75
Some clinical features of tuberculosis. 1. Incubation period.
POULSEN, A. (1950) · PubMed · Cited by 74
Lawn, S. D., Kerkhoff, A. D., Vogt, M., Ghebrekristos, Y. T., Whitelaw, A. C., & Wood, R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1039 · Cited by 73
Diacon, A. H., Maritz, J. S., Venter, A., et al. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1043-7 · Cited by 71
Fitzwater, S. P., Caviedes, L., Gilman, R. H., Coronel, J., LaChira, D., Salazar, C., Saravia, J. C., Reddy, K. P., Friedland, J. S., & Moore, D. (2010) · Clinical Infectious Diseases · doi:10.1086/655127 · Cited by 71
Some clinical features of tuberculosis.
Poulsen, A. D. (1957) · PubMed · Cited by 70
Antituberculosis Drugs and Hepatotoxicity
Yew, W. W., & Leung, C. C. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.175.8.858 · Cited by 69
Self-citationAlffenaar, J. C., van Altena, R., Harmelink, I. M., Filguera, P., Molenaar, E., Wessels, A. M. A., van Soolingen, D., Kosterink, J. G. W., Uges, D. R. A., & van der Werf, T. S. (2010) · Clinical Pharmacokinetics · doi:10.2165/11532080-000000000-00000 · Cited by 67
Self-citationMaterial incentives and enablers in the management of tuberculosis
Lutge, E. E., Wiysonge, C. S., Knight, S. E., & Volmink, J. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007952.pub2 · Cited by 66
Donald, P. R. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540152029954 · Cited by 66
Population Pharmacokinetics of Linezolid in Adults with Pulmonary Tuberculosis
McGee, B., Dietze, R., Hadad, D. J., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01378-08 · Cited by 63
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action
Wells, W. A., Boehme, C. C., Cobelens, F. G. J., Daniels, C., Dowdy, D. W., Gardiner, E., Gheuens, J., Kim, P. S., Kimerling, M. E., Kreiswirth, B. N., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70025-2 · Cited by 61
High-Dose Isoniazid Therapy for Isoniazid-Resistant Murine Mycobacterium tuberculosis Infection
Cynamon, M. H., Zhang, Y., Harpster, T. S., Cheng, S. J., & DeStefano, M. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2922 · Cited by 60
A New Perspective on John Snow's Communicable Disease Theory
Winkelstein, W. (1995) · American Journal of Epidemiology · doi:10.1093/aje/142.supplement_9.s3 · Cited by 51
Population Pharmacokinetics of Ethambutol in South African Tuberculosis Patients
Jönsson, S., Davidse, A., Wilkins, J. J., van der Walt, J., Simonsson, U. S. H., Karlsson, M. O., Smith, P. J., & McIlleron, H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00274-11 · Cited by 51
Effect of Treatment on Contagiousness of Patients with Active Pulmonary Tuberculosis
Menzies, D. (1997) · Infection Control and Hospital Epidemiology · doi:10.2307/30141272 · Cited by 50
Self-citationvan der Werf, M. J., Langendam, M. W., Sandgren, A., et al. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0437 · Cited by 48
Self-citationGelmanova, I. Y., Taran, D., Mishustin, S. P., Golubkov, A., Solovyova, A. V., & Keshavjee, S. A. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0531 · Cited by 47
Linezolid in the treatment of MDR-TB: a retrospective clinical study
Xu, H.-B., Jiang, R.-H., Li, L., & Xiao, H.-P. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0493 · Cited by 45
Active case finding in contacts of people with tuberculosis
Fox, G. J., Dobler, C. C., & Marks, G. B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008477.pub2 · Cited by 44
Malla, P., Kanitz, E. E., Akhtar, M., Falzon, D., Feldmann, K., Gunneberg, C., Jha, S. S., Maharjan, B., Prasai, M. K., Shrestha, B., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008313 · Cited by 43
Minion, J., Gallant, V., Wolfe, J. N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053466 · Cited by 43
Seddon, J. A., Hesseling, A. C., Godfrey‐Faussett, P., Fielding, K., & Schaaf, H. S. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-392 · Cited by 35
Changes in the epidemiology of tuberculosis: the influence of international migration flows
Fortün, J., Martín‐Dávila, P., Navas, E., López‐Vélez, R., Pintado, V., Cobo, J., García, A. G., Bonilla, M., Aneiros, V., Gómez-Mampaso, E., et al. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.04.002 · Cited by 29
Hypothyroidism due to ethionamide
McDonnell, M. E., Braverman, L. E., & Bernardo, J. (2005) · New England Journal of Medicine · doi:10.1056/nejm200506303522621 · Cited by 27
The Association between Symptoms and Microbiologically Defined Response to Tuberculosis Treatment
Hales, C. M., Heilig, C. M., Chaisson, R. E., Leung, C. C., Chang, K. C., GOLDBERG, S. V., Gordin, F. M., Johnson, J. L., Muzanyi, G., Saukkonen, J. J., et al. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201207-038oc · Cited by 27
Self-citationBonacci, R. A., Cruz‐Hervert, L. P., García‐García, L., Reynales-Shigematsu, L. M., Ferreyra-Reyes, L. D., Bobadilla-del-Valle, M., Canizales‐Quintero, S., Ferreira-Guerrero, E., Báez-Saldaña, R., Téllez-Vázquez, N. A., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.09.005 · Cited by 27
Brewer, T. F., Choi, H. W., Seas, C., Krapp, F., Zamudio, C., Shah, L., Ciampi, A., Heymann, J. S., & Gotuzzo, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025861 · Cited by 24
Hearing loss in the child following streptomycin administration during pregnancy.
Donald, P. R., Doherty, E., & Zyl, F. J. V. (1991) · PubMed · Cited by 15
Tuberculosis: are we making it incurable?
Caminero, J. A., Matteelli, A., & Loddenkemper, R. (2013) · European Respiratory Journal · doi:10.1183/09031936.00206712 · Cited by 14
Self-citationXDR-TB in South Africa: Detention Is Not the Priority
Goemaere, E., Ford, N. P., Berman, D., McDermid, C., & Cohen, R. E. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040162 · Cited by 11
Multidrug- and extensively drug-resistant TB in persons living with HIV
Matteelli, A., Richardson, M. D. A., Sotgiu, G., Centis, R., & Migliori, G. B. (2009) · Expert Review of Respiratory Medicine · doi:10.1586/ers.09.15 · Cited by 10
Self-citation
Cited by
Towards tuberculosis elimination: an action framework for low-incidence countries
Lönnroth, K., Migliori, G. B., Abubakar, I., D'Ambrosio, L., de Vries, G., Diel, R., Douglas, P., Falzon, D., Gaudreau, M.-A., Goletti, D., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00214014 · Cited by 778
Self-citationDheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Self-citationDheda, K., Barry, C. E., & Maartens, G. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00151-8 · Cited by 599
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences
Coll, F., McNerney, R., Preston, M. D., Guerra-Assunção, J. A., Warry, A., Hill-Cawthorne, G., Mallard, K., Nair, M., Miranda, A., Alves, A., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0164-0 · Cited by 420
Horsburgh, C. R., Barry, C. E., & Lange, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1413919 · Cited by 323
Self-citation
Metadata
- Authors
- Lange, C., Abubakar, I., Alffenaar, J.-W. C., Bothamley, G., Caminero, J. A., Carvalho, A. C. C., Chang, K.-C., Codecasa, L., Correia, A., Crudu, V., Davies, P., Dedicoat, M., Drobniewski, F., Duarte, R., Ehlers, C., Erkens, C., Goletti, D., Günther, G., Ibraim, E., Kampmann, B., Kuksa, L., de Lange, W., van Leth, F., van Lunzen, J., Matteelli, A., Menzies, D., Monedero, I., Richter, E., Rüsch-Gerdes, S., Sandgren, A., Scardigli, A., Skrahina, A., Tortoli, E., Volchenkov, G., Wagner, D., van der Werf, M. J., Williams, B., Yew, W.-W., Zellweger, J.-P., & Cirillo, D. M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2014-03-23
- Volume
- 44
- Issue
- 1
- Pages
- 23-63
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2164091066
- Cited by
- 310
- References
- 177
- FWCI
- 30.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.